Biological materials and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 1, 2004
app pub date -
Nov 26, 2003
filing date -
Nov 17, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to the use of cpn 10 from Mycobacterium tuberculosis, or functionally equivalent molecules of fragments thereof, in the prevention and/or treatment of allergic conditions such as asthma, rhinitis/hay fever, eczema and anaphylaxis, which conditions are associated with an underlying Th2 cell over-reactivity, or cancerous conditions.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully